JOINT Corp (NASDAQ: JYNT)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0001612630
Market Cap 132.99 Mn
P/B 5.86
P/E 68.77
P/S 77.74
ROIC (Qtr) 8.07
Div Yield % 0.00
Rev 1y % (Qtr) 5.74
Total Debt (Qtr) 2.09 Mn
Debt/Equity (Qtr) 0.09

About

Joint Corp, also known as JYNT, is a company that operates within the chiropractic industry. It has experienced significant growth, expanding its operation from eight to 935 clinics as of December 31, 2023. The company's mission is to enhance the quality of life through regular and affordable chiropractic care. Joint Corp's primary business activities revolve around providing chiropractic services, wellness treatment plans, and membership programs. These services are offered in a retail, consumer-driven setting, making them accessible and convenient...

Read more

Price action

Investment thesis

Bull case

  • Strong operating cash flow of 3.07M provides robust 1.47x coverage of total debt 2.09M, indicating excellent debt servicing capability and financial flexibility.
  • Healthy cash reserves of 30.71M provide 160.26x coverage of short-term debt 191641, demonstrating strong liquidity position and minimal refinancing risk.
  • Strong tangible asset base of 69.39M provides 33.18x coverage of total debt 2.09M, indicating robust asset backing and low credit risk.
  • Cash reserves of 30.71M provide ample 3.86x coverage of acquisition spending 7.96M, enabling strategic growth opportunities.
  • Cash reserves of 30.71M provide robust 0.93x coverage of current liabilities 33.05M, indicating strong short-term solvency.

Bear case

  • Operating cash flow of 3.07M barely covers its investment activities of 6.52M, with a coverage ratio of 0.47, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Operating cash flow of 3.07M provides insufficient coverage of deferred revenue obligations of 14.51M, which is 0.21x, raising concerns about future service delivery capabilities.
  • The company's operating cash flow of 3.07M shows concerning coverage of stock compensation expenses of 1.17M, with a 2.61 ratio indicating potential earnings quality issues.
  • Operating cash flow of 3.07M provides minimal -8.10x coverage of tax expenses of (379088), suggesting potential tax planning inefficiencies or unsustainable tax positions.
  • Free cash flow of 1.63M represents just -150.81x of debt issuance (10825), suggesting concerning reliance on leverage rather than internal cash generation for growth.

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 114.88 Bn 18.11 1.54 46.35 Bn
2 THC Tenet Healthcare Corp 18.07 Bn 13.34 0.87 13.19 Bn
3 UHS Universal Health Services Inc 14.64 Bn 10.65 0.86 5.11 Bn
4 FMS Fresenius Medical Care AG 14.10 Bn 16.69 0.61 14.98 Bn
5 EHC Encompass Health Corp 12.55 Bn 19.95 2.17 2.66 Bn
6 ENSG Ensign Group, Inc 10.08 Bn 30.72 2.09 2.16 Bn
7 DVA Davita Inc. 8.90 Bn 11.53 0.67 12.78 Bn
8 CHE Chemed Corp 6.38 Bn 22.87 2.52 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 1.48 1.26
EV to Cash from Ops. EV/CFO 33.48 12.78
EV to Debt EV to Debt 49.17 12.10
EV to EBIT EV/EBIT 66.13 10.74
EV to EBITDA EV/EBITDA 26.54 16.04
EV to Free Cash Flow [EV/FCF] EV/FCF 62.98 18.02
EV to Market Cap EV to Market Cap 0.78 432.64
EV to Revenue EV/Rev 60.10 2.77
Price to Book Value [P/B] P/B 5.80 -1.92
Price to Earnings [P/E] P/E 68.08 5.13
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 0.10
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 -13.44
Dividend per Basic Share Div per Share (Qtr) 0.00 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 5.42
Interest Coverage Interest Coverage 0.00 -97.94
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 30.41 -114.65
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 39.63 65.22
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.97
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 111.47 -46.98
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -28.26 75.97
EBIT Growth (1y) % EBIT 1y % (Qtr) 124.68 -61.19
EBT Growth (1y) % EBT 1y % (Qtr) 124.68 -115.48
EPS Growth (1y) % EPS 1y % (Qtr) 111.40 -24.32
FCF Growth (1y) % FCF 1y % (Qtr) -75.27 309.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 28.62 17.88
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.02 1.04
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.04
Cash Ratio Cash Ratio (Qtr) 0.93 0.39
Current Ratio Curr Ratio (Qtr) 1.83 1.39
Debt to Equity Ratio Debt/Equity (Qtr) 0.09 -13.19
Interest Cover Ratio Interest Cover Ratio 0.00 -97.94
Times Interest Earned Times Interest Earned 0.00 -97.94
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 197.60 -95.81
EBIT Margin % EBIT Margin % (Qtr) 90.88 -94.97
EBT Margin % EBT Margin % (Qtr) 90.88 -105.60
Gross Margin % Gross Margin % (Qtr) -575.50 23.31
Net Profit Margin % Net Margin % (Qtr) 113.00 -106.14